Ene M D, Williamson P J, Daneshmend T K, Blatchford N R
Br J Clin Pharmacol. 1984 Feb;17(2):173-5. doi: 10.1111/j.1365-2125.1984.tb02334.x.
Eight healthy female subjects were each given (a) ketoconazole 400 mg orally, (b) ketoconazole 400 mg as a single vaginal pessary, (c) ketoconazole 800 mg as two vaginal pessaries, and (d) ketoconazole 1200 mg as three vaginal pessaries. The area under the plasma concentration time curve (AUC) after the oral dose was 51.41 +/- 10.99 mg l-1 h (mean +/- s.d.) and the half-life of ketoconazole was 2.98 +/- 1.41 h. The AUCs after vaginal administration were 0.27 +/- 0.14, 0.52 +/- 0.25, and 0.43 +/- 0.22 mg-1 l h following the 400, 800 and 1200 mg pessaries respectively. Systemic absorption of single doses of vaginally administered ketoconazole appears to be negligible in the absence of vaginal infection. There were no local or systemic side effects related to ketoconazole in these healthy volunteers.
(a)口服400毫克酮康唑;(b)单次阴道栓剂给药400毫克酮康唑;(c)两次阴道栓剂给药800毫克酮康唑;(d)三次阴道栓剂给药1200毫克酮康唑。口服给药后血浆浓度-时间曲线下面积(AUC)为51.41±10.99毫克·升⁻¹·小时(平均值±标准差),酮康唑的半衰期为2.98±1.41小时。阴道给药后,400毫克、800毫克和1200毫克栓剂的AUC分别为0.27±0.14、0.52±0.25和0.43±0.22毫克⁻¹·升·小时。在无阴道感染的情况下,单次阴道给药酮康唑的全身吸收似乎可忽略不计。这些健康志愿者中未出现与酮康唑相关的局部或全身副作用。